NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ecolab Triple Antibiotic | BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Ecolabs Food Safety Specialties, Inc. | 4aef8f98-db76-07f2-e054-00144ff8d46c | 2025-09-09 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | d265f094-e654-4c68-9215-b5d061af885d | 2025-09-08 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 2025-09-08 | Warnings | M004 89Y4M234ES |
| Thompson Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Thompson | f883c4cb-c32c-76e3-e053-6294a90aa4fc | 2025-09-08 | Warnings | M004 89Y4M234ES |
| Thompson Triple Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE | Thompson | de9489de-e677-2bd3-e053-2a95a90acfb4 | 2025-09-08 | Warnings | M004 89Y4M234ES |
| Jack Black L.L.C. | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 3e0eb291-6bda-2f26-e063-6294a90ac466 | 2025-09-05 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 3d5fafb9-62c9-ec69-e063-6394a90af8b9 | 2025-09-05 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 3e0f655e-6100-f1dd-e063-6394a90af7b7 | 2025-09-05 | Warnings | 4T6H12BN9U |
| BACITRACIN ZINC | FIRST AID ANTIBIOTIC | Encube Ethicals, Inc. | 613cbed4-9790-4e6b-a61b-b7b7a8ee59c9 | 2025-09-04 | Warnings | M004 1366116 89Y4M234ES |
| Antibiotic Maximum Strength | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Walgreens | 9a092f24-65b2-4b57-8103-265ea3e03311 | 2025-09-02 | Warnings | M004 89Y4M234ES |
| Aerosoothe | TRIPLE ANTIBIOTIC OINTMENT | Aero Healthcare US LLC | 2287a31c-750c-728d-e054-00144ff88e88 | 2025-08-29 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Chain Drug Marketing Association Inc. | 3d4b3d73-171a-bc6a-e063-6394a90a69c1 | 2025-08-26 | Warnings | M004 89Y4M234ES |
| ProCure HydroCerin | PETROLATUM 33% | Twin Med LLC | 3d379d5b-e939-9391-e063-6294a90a375c | 2025-08-25 | Warnings | 4T6H12BN9U |
| Pure Petrolatum Jelly | PETROLATUM | MY IMPORTS USA LLC | 3d1fd588-8d16-509c-e063-6394a90ad025 | 2025-08-24 | Warnings | 4T6H12BN9U |
| Kidgets Baby Petroleum Jelly | BABY PETROLEUM JELLY | MY IMPORTS USA LLC | 3d2000da-a173-1fc3-e063-6294a90ad3a9 | 2025-08-24 | Warnings | 4T6H12BN9U |
| Dual Action Cream | NEOMYCINSULFATE,POLYMYXINBSULFATE,PRAMOXINEHCL | Trifecta Pharmaceutical USA LLC | b84015ae-9c76-b1d7-e053-2a95a90a2cc8 | 2025-08-23 | Warnings | M004 |
| Pure Petrolatum Jelly | PETROLATUM | MY IMPORTS USA LLC | 3cf22c5a-f9a0-4bfb-e063-6394a90af8dd | 2025-08-22 | Warnings | 4T6H12BN9U |
| Kidgets Baby Petroleum Jelly with Vitamin A D | LANOLIN, PETROLATUM | MY IMPORTS USA LLC | 3cf37fa7-6be4-b835-e063-6394a90ad406 | 2025-08-22 | Warnings | 4T6H12BN9U |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | 4T6H12BN9U T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.